Epithelial-Derived Cytokines in Asthma

Patrick Mitchell, Paul O'Byrne

Research output: Contribution to journalArticlepeer-review


The interaction between the airway epithelium and the inhaled environment is crucial to understanding the pathobiology of asthma. Several studies have identified an important role of airway epithelial-derived cytokines, IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) in asthma pathogenesis. These cytokines have been described as epithelial-derived alarmins that activate and potentiate the innate and humoral arms of the immune system in the presence of actual or perceived damage. Each of the three epithelial-derived alarmins has been implicated in the pathobiology of inhaled allergen-induced airway responses. The best evidence to date exists for TSLP, in that a human monoclonal antibody, which binds TSLP and prevents its engagement with its receptor, resolves airway inflammation in patients with allergic asthma and attenuates allergen-induced airway responses. Better understanding the roles that the epithelial-derived alarmins play and how they influence airway immune response may allow the development of novel therapeutics for asthma treatment.
Original languageEnglish
Article numberPMID: 27818325
Pages (from-to)1338-1344
Issue number6
Early online date3 Nov 2016
Publication statusPublished - 2017


Dive into the research topics of 'Epithelial-Derived Cytokines in Asthma'. Together they form a unique fingerprint.

Cite this